Jazz Pharmaceuticals plc buy Royal Bank of Canada
Start price
29.02.24
/
50%
€109.90
Target price
28.02.25
€180.57
Performance (%)
-4.55%
Price
13.05.24
€104.90
Summary
This prediction is currently active. With a performance of -4.55%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 28.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 2.843% | 2.843% |
| iShares Core DAX® | 2.749% | 4.620% |
| iShares Nasdaq 100 | 0.470% | -0.331% |
| iShares Nikkei 225® | -2.930% | -5.556% |
| iShares S&P 500 | 0.679% | 0.631% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€110.15
09.11.23
09.11.23
€178.99
09.11.24
09.11.24
-5.49%
13.05.24
13.05.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€123.15
10.08.23
10.08.23
€182.37
10.08.24
10.08.24
-14.82%
13.05.24
13.05.24